Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Filings indexed 708 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
zal01_Sprawozdanie_z_badania_SSF_-_Grupa_Celon_Pharma_-_22.04.2026_2026_04_22_19_19_41.xhtml.xades
Regulatory Filings
2026-04-22 Polish
Sprawozdanie z badania SSF
Regulatory Filings
2026-04-22 Polish
zal08_CLN-ASZR-SBR-2025-12-31-1-pl.xhtml.XAdES
Regulatory Filings
2026-04-22 Polish
Atestacja Zrównoważonego Rozwoju 2025
Regulatory Filings
2026-04-22 Polish
List do akcjonariuszy
Regulatory Filings
2026-04-22 Polish
Pcena RN_KA
Regulatory Filings
2026-04-22 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.